Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer.

Journal of experimental & clinical cancer research : CR - 28 Jun 2018

Chen Jing, Cao Shunwang, Situ Bo, Zhong Juan, Hu Yanwei, Li Shufen, Huang Jinlan, Xu Jiasen, Wu Shiyang, Lin Jinduan, Zhao Qianwen, Cai Zhen, Zheng Lei, Wang Qian

Abstract excerpt

BACKGROUND: Circulating tumor cells (CTCs), an advantageous target of liquid biopsy, is an important biomarker for the prognosis and monitoring of cancer. Currently, detection techniques for CTCs are mainly based on the physical and/or epithelial characteristics of tumor cells. However, biofunctional activity markers that can indicate the high metastatic capacity of CTCs are lacking. METHODS: Functional...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Energy Metabolism
Share to Epithelial-Mesenchymal Transition

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunophenotyping

Share to Neoplasm Metastasis

Share to Neoplasm Staging

Share to Neoplastic Cells, Circulating

Share to Prostatic Neoplasms

Share to ROC Curve

Source

Open in PubMed Open full text

Identifiers

PMID: 29954422
DOI: 10.1186/s13046-018-0789-0
PMCID: PMC6025832

Genes

PGK1
PDK1
PDP2
PYGL

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer.PMID 29954422Read ↗

Identification of Metabolism-Associated Prostate Cancer Subtypes and Construction of a Prognostic Risk ModelSemantic proximity Read ↗

A Novel Risk Factor Model Based on Glycolysis-Associated Genes for Predicting the Prognosis of Patients With Prostate CancerSemantic proximity Read ↗

Precise Detection and Transcriptomic Concordant Analysis of Circulating Tumor Cells from Prostate CancerSemantic proximity Read ↗

A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy.Semantic proximity Read ↗

TMPO promotes cellular dissemination and metastasis in circulating tumor cellsSemantic proximity Read ↗

Metabolic deregulation in prostate cancerSemantic proximity Read ↗

Single-cell analysis revealing the metabolic landscape of prostate cancerSemantic proximity Read ↗

Cancer-associated fibroblasts promote prostate cancer malignancy via metabolic rewiring and mitochondrial transferSemantic proximity Read ↗

Personalized Medicine for Prostate Cancer: Is Targeting Metabolism a Reality?Semantic proximity Read ↗

Metabolism-Related Gene Expression in Circulating Tumor Cells from Patients with Early Stage Non-Small Cell Lung CancerSemantic proximity Read ↗

Radiogenomic analysis of ultrasound phenotypic features coupled to proteomes predicts metastatic risk in primary prostate cancer.Semantic proximity Read ↗

Global Gene Expression Characterization of Circulating Tumor Cells in Metastasic Castration-Resistant Prostate Cancer PatientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.